Herbalife Ltd (HLF)

HLF (NYSE:Consumer Non-Durables) EQUITY
$67.01
neg -0.08
-0.12%
Today's Range: 66.39 - 67.32 | HLF Avg Daily Volume: 2,151,100
Last Update: 07/28/16 - 3:59 PM EDT
Volume: 1,236,328
YTD Performance: 25.12%
Open: $67.11
Previous Close: $67.09
52 Week Range: $42.26 - $72.22
Oustanding Shares: 92,800,128
Market Cap: 6,249,160,620
6-Month Chart
TheStreet Ratings Grade for HLF
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 3.00 3.00 3.00 3.00
Latest Dividend: 0.30
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 02/28/14
Price Earnings Ratio: 19.92
Price Earnings Comparisons:
HLF Sector Avg. S&P 500
19.92 16.20 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
12.38% 38.73% 14.78%
GROWTH 12 Mo 3 Yr CAGR
Revenue -9.90 0.10 0.03
Net Income 9.80 -0.30 -0.11
EPS 16.80 0.00 -0.01
Earnings for HLF:
EBITDA 1.93B
Revenue 4.47B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.17 $1.17 $4.82 $5.20
Number of Analysts 1 1 2 2
High Estimate $1.17 $1.17 $4.97 $5.25
Low Estimate $1.17 $1.17 $4.68 $5.15
Prior Year $1.24 $1.28 $5.00 $4.82
Growth Rate (Year over Year) -5.65% -8.59% -3.50% 7.77%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
The FTC has effectively shut Herbalife down but investors just don't realize it, Ackman says.
He needs Mondelez to make a deal -- any deal.
It looks like the billionaire activist can't catch a break on these two stocks.
If you aren’t a big fund manager, you don’t have to trade like one.
Anything above that, you speculate on Ackman vs. Icahn.
Herbalife stock lifted on FTC investigation results while Xerox reportedly rejects R.R. Donnelley's merger proposal.
Valeant Pharmaceuticals is not letting up on Ackman's fund, dragging 2016 losses down by more than 20%.
The drama between the billionaire activist and Herbalife heats up in a new Pershing Square video attack.
Shares of the nutrition-products distributor fall from their Wednesday highs on news that Herbalife's much-awaited FTC settlement will not come this week.
Investors should be wary of the increasingly popular activist short-sellers.

Columnist Conversations

Markets mixed as we head to the last hour of trading.  Oil continues to fall and edgy closer and closer t...
Natural Gas has exploded to the upside today in reaction to a much less than expected build in inventories dur...
As I like to preach in our chat room and webinars, we are in the MOVING business, not the STORAGE business.&nb...
Market opens slightly down and oil continuing to struggle.   Some notes on quarterly reports this morn...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.